Magdalena Król Selected Research

Surgical Amputation (Amputations)

1/2021

Factors determining acceptance of disease and its impact on satisfaction with life of patients with peripheral artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Król Research Topics

Disease

23	Neoplasms (Cancer) 09/2021 - 10/2011
8	Breast Neoplasms (Breast Cancer) 10/2018 - 10/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2015
4	Fibrosarcoma 02/2017 - 12/2013
3	Neoplasm Metastasis (Metastasis) 01/2013 - 10/2011
2	Inflammation (Inflammations) 12/2020 - 02/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 01/2016
1	Cardiotoxicity 09/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Peripheral Arterial Disease 01/2021
1	Circulating Neoplastic Cells 10/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 02/2017
1	Anemia 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 12/2013
1	Adenocarcinoma 01/2013
1	Carcinoma (Carcinomatosis) 09/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2018 - 02/2012
4	MicroRNAs (MicroRNA)IBA 10/2018 - 01/2014
3	AntigensIBA 10/2018 - 10/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017 - 01/2015
3	GoldIBA 02/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 10/2011
2	Glycoproteins (Glycoprotein)IBA 02/2017 - 06/2012
2	Annexin A5IBA 01/2015 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 02/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2020
1	hemoglobin ASIBA 07/2020
1	Drug CarriersIBA 07/2020
1	Carcinoembryonic AntigenIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Cadherins (E-Cadherin)IBA 10/2018
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 10/2018
1	fluoromisonidazoleIBA 01/2018
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2018
1	pimonidazoleIBA 01/2018
1	ApoferritinsIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 02/2017
1	Caspase 3 (Caspase-3)IBA 04/2016
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2016
1	AgarIBA 01/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2016
1	Thyroid HormonesIBA 01/2016
1	methylaniline (N-methylaniline)IBA 01/2016
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2016
1	EndocannabinoidsIBA 01/2016
1	Corn Oil (Oil, Corn)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2015
1	Propidium (Propidium Iodide)IBA 01/2015
1	Verapamil (Calan)FDA LinkGeneric 01/2015
1	Rhodamine 123IBA 01/2015
1	Conditioned Culture MediaIBA 01/2014
1	VimentinIBA 12/2013
1	RelaxinIBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	Cisplatin (Platino)FDA LinkGeneric 06/2013
1	Vinblastine (Vinblastine Sulfate)FDA Link 06/2013
1	multidrug resistance-associated protein 1IBA 06/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2013
1	Complement System Proteins (Complement)IBA 04/2013
1	Macrophage Colony-Stimulating FactorIBA 04/2013
1	Actins (F Actin)IBA 01/2013
1	migrastatinIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	GhrelinIBA 09/2012
1	Biological ProductsIBA 09/2012
1	Ghrelin ReceptorsIBA 09/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 06/2012
1	CarbohydratesIBA 06/2012
1	matrigelIBA 03/2012
1	CytokinesIBA 02/2012
1	ChemokinesIBA 02/2012
1	Semaphorins (Semaphorin)IBA 10/2011
1	NeuropilinsIBA 10/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 09/2021 - 02/2017
2	Radiotherapy 02/2017 - 12/2016
2	Therapeutics 01/2016 - 01/2013
1	Kidney Transplantation 01/2021
1	Surgical Amputation (Amputations) 01/2021
1	Precision Medicine 08/2014